Product image of Metoprolol Lph (Metoprolol Tartrate) supplied by GNH India

Metoprolol Lph

Active Ingredient:
Metoprolol Tartrate
Origin:
EU

Metoprolol Lph (Metoprolol Tartrate)

Metoprolol tartrate, the active ingredient in Metoprolol Lph, is a beta blocker presented as an oral tablet for systemic use. It lowers elevated blood pressure, relieves angina, and improves outcomes after myocardial infarction and in chronic heart failure, primarily in adult patients.

GNH India supplies Metoprolol Lph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing batch‑tested product for global distribution.

Manufacturer / TM Owner

Labormed Pharma S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Metoprolol tartrate is used to manage cardiovascular conditions that involve excessive sympathetic activity.
  • Hypertension: reduces systolic and diastolic blood pressure.
  • Angina pectoris: decreases myocardial oxygen demand and relieves chest pain.
  • Post‑myocardial infarction: lowers risk of recurrent ischemic events and improves survival.
  • Heart failure: improves left‑ventricular function and reduces hospitalisation.
  • Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other tachyarrhythmias.

How It Works

  • Metoprolol tartrate selectively blocks β1‑adrenergic receptors in cardiac tissue, diminishing sympathetic stimulation. This results in a slower heart rate, reduced myocardial contractility, and lower cardiac output, which together lower arterial pressure and decrease myocardial oxygen consumption.

Side Effects

Metoprolol tartrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Fatigue or tiredness
  • Dizziness or light‑headedness
  • Bradycardia (slow heart rate)
  • Cold extremities
  • Gastrointestinal upset (nausea, abdominal discomfort)
  • Headache

Serious or Rare Side Effects

  • Severe bradycardia or heart block
  • Marked hypotension
  • Bronchospasm, especially in patients with asthma or COPD
  • Allergic reactions such as rash, angioedema, or anaphylaxis
  • Depression or mood changes
  • Worsening heart failure symptoms

Precautions & Warnings

  • When prescribing metoprolol tartrate, clinicians should observe several precautionary measures to ensure safe use.
  • Monitor blood pressure: check regularly to avoid excessive hypotension.
  • Assess heart rate: watch for bradycardia, especially in patients with conduction disorders.
  • Review cardiac function: consider baseline ejection fraction and recent myocardial events.
  • Adjust in renal/hepatic impairment: dose may need reduction in patients with organ dysfunction.
  • Caution in asthma or COPD: β1‑selectivity may not fully prevent bronchospasm.
  • Store at ambient temperature: keep in the original container, protect from moisture.

Avoid Interactions

Metoprolol tartrate can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Concomitant use with non‑dihydropyridine calcium‑channel blockers (verapamil, diltiazem) may cause profound bradycardia or AV block.
  • Co‑administration with clonidine followed by abrupt discontinuation can precipitate severe hypertension.
  • Combined with insulin or oral hypoglycemics may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely)

  • NSAIDs may reduce the antihypertensive effect of metoprolol.
  • Diuretics can potentiate hypotensive responses.
  • Other beta‑blockers increase the risk of excessive bradycardia.
  • Certain antidepressants (e.g., SSRIs) may affect plasma concentrations of metoprolol.

Frequently Asked Questions

Metoprolol Lph contains metoprolol tartrate, a beta‑blocker indicated for the treatment of hypertension, stable angina pectoris, post‑myocardial infarction care, chronic heart failure, and for rate control in certain cardiac arrhythmias such as atrial fibrillation.

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, reducing sympathetic stimulation. This slows the heart rate, lowers myocardial contractility, and decreases cardiac output, which together lower blood pressure and reduce the heart’s oxygen demand.

The appropriate dose of Metoprolol Lph is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any co‑existing health issues. Dosage regimens are not disclosed here and should follow the prescriber’s instructions.

Safety data for metoprolol tartrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol tartrate is a cardio‑selective (β1‑selective) agent, offering a lower risk of bronchospasm compared with non‑selective beta‑blockers such as propranolol. Compared with atenolol, metoprolol has a shorter half‑life and may require twice‑daily dosing, but both share similar efficacy for blood‑pressure control.

Metoprolol Lph should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiry date printed on the label.

Metoprolol Lph is administered orally, usually as a tablet that is swallowed whole with water. It may be taken with or without food, but patients should follow the specific timing and dosing instructions provided by their prescriber.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience fainting, severe shortness of breath, or signs of an allergic response.

Metoprolol Lph is contraindicated in patients with known hypersensitivity to metoprolol or any excipients, those with severe bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, cardiogenic shock, and in individuals with uncompensated severe asthma or COPD.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metoprolol Tartrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT